BioSpace News Archive

Cerner Corporation (Nasdaq: CERN), a global health care technology company, is now offering select U.S. health systems and academic research centers complimentary access to critical de-identified COVID-19 patient data to help fight the pandemic. This offering will provide eligible health care researchers free access to Cerner’s COVID-19 data set to support epidemiological studies, clinical trials and medical treatments related to COVID-1

Voltron Therapeutics, Inc. announced today that it has selected the peptides required to complete the structure of HaloVax for development and progression into pre-clinical animal testing of the HaloVax Self-Assembling Vaccine (SAV).

The American College of Emergency Physicians is pleased to announce that Susan Sedory, MA, CAE, will be its next Executive Director.

10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2020 after market close on Monday, May 11, 2020. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.10

Submissions demonstrate Janssen’s commitment to developing new options for young patients

Skydio Inc. today announced two initiatives to support America’s first responders with drones and personal protection equipment. The first initiative, the Skydio Emergency Response Program (ERP), will donate dozens of Skydio 2 drones and associated equipment to public safety agencies across the country.

Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2019 Universal Registration Document (Document d’enregistrement universel) for the year ended December 31, 2019 with the French market authority “Autorité des Marchés Financiers” (“AMF”)

FHLB Cincinnati is expanding availability of discounted Advances to help members address the impact of the novel coronavirus (COVID-19) pandemic in their communities.

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its first quarter 2020 financial results on Monday, May 11, before the open of the U.S. financial markets.

Sensorion a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, rescheduled its General Assembly to Wednesday, May 20, 2020.